ONC

AS OF

Dec 24 closing price

Price

$311.73

Change

-$0.59 (-0.19%)

Capitalization

35.81B

97 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ONC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BeOne Medicines (ONC) Ownership - Who owns BeOne Medicines?

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A

Details

Group

Domestic Stock Funds

Fundamentals

ONC

Capitalization

35.8B

P/E Ratio

599.48

Risk (Beta)

0.31

Dividend Yield

N/A

Total Cash

4.04B

Total Cash/Share

36.48

Total Debt

1.02B

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

44.68%

Revenue

4.97B

ROE

N/A

Book Value

4.13B

P/B Ratio

8.35

Cash Flow

N/A

Earnings

0.65

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

144K

Current Ratio

2.39

Current Revenue Per Employee

128389.45

Dividends Per Share - Security

N/A

EBITDA

339M

Float

N/A

Float - Current

N/A

Gross Income Margin

86.09

Revenue To Assets

1.02

Shares Held By Institutions

32.3B

Shares Outstanding - Current

111M

Total Liabilities

3.5B

Total Volume MTD

N/A

Value

-1

Gain YTD

68.767

View a ticker or compare two or three

Compare

ONC

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ONC showed earnings on November 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading for ONC

A.I. Advisor

published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology